KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veon (VEON) Cash & Equivalents (2016 - 2025)

Veon's Cash & Equivalents history spans 10 years, with the latest figure at $1.7 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 2.55% year-over-year to $1.7 billion; the TTM value through Dec 2025 reached $1.7 billion, up 2.55%, while the annual FY2025 figure was $1.7 billion, 2.55% up from the prior year.
  • Cash & Equivalents reached $1.7 billion in Q4 2025 per VEON's latest filing, up from $1.7 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.7 billion in Q4 2025 to a low of $4.0 million in Q4 2023.
  • Average Cash & Equivalents over 5 years is $697.0 million, with a median of $54.0 million recorded in 2021.
  • Peak YoY movement for Cash & Equivalents: crashed 88.89% in 2022, then soared 42125.0% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $54.0 million in 2021, then plummeted by 88.89% to $6.0 million in 2022, then tumbled by 33.33% to $4.0 million in 2023, then skyrocketed by 42125.0% to $1.7 billion in 2024, then grew by 2.55% to $1.7 billion in 2025.
  • Per Business Quant, the three most recent readings for VEON's Cash & Equivalents are $1.7 billion (Q4 2025), $1.7 billion (Q4 2024), and $4.0 million (Q4 2023).